Medication info
Pamilan Tablet 20mg (Famotidine)

Pamilan Tablet 20mg (Famotidine)

Prescription medicationTabletOral
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Light green round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000321 · Approved 2020.01.21 · Insurance code 669907870

Summary

Main use
Treatment of acid-related disorders (including ulcers and reflux esophagitis) and upper gastrointestinal bleeding; improvement of gastritis-related mucosal lesions
Who takes it
Adults
Adult dose
1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic ulcer), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at a dose of 20 mg twice daily (after breakfast and dinner, or at bedtime), or 40 mg once daily (at bedtime). In cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation and switched to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10 mg twice daily (after breakfast and dinner, or at bedtime), or 20 mg once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (including ulcers and reflux esophagitis) and upper gastrointestinal bleeding; improvement of gastritis-related mucosal lesions

  • Gastric and duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal bleeding
  • acute stress ulcers
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • hemorrhage
  • redness
  • swelling
View approved original text

This medication is effective for gastrointestinal ulcer diseases such as gastric and duodenal ulcers, anastomotic ulcers, and upper gastrointestinal bleeding. It also helps in cases of bleeding due to acute stress ulcers and hemorrhagic gastritis. It is used in patients with gastroesophageal reflux disease to alleviate symptoms and adjusts conditions of excessive gastric acid secretion such as Zollinger-Ellison syndrome. It aids in the improvement of gastric mucosal lesions such as erosion, hemorrhage, redness, and swelling that occur during acute exacerbations of acute gastritis and chronic gastritis. Overall, it effectively treats and improves mucosal damage in gastrointestinal diseases.

How to take

Adult dose

1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic ulcer), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at a dose of 20 mg twice daily (after breakfast and dinner, or at bedtime), or 40 mg once daily (at bedtime). In cases of upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation and switched to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10 mg twice daily (after breakfast and dinner, or at bedtime), or 20 mg once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used in patients with allergic reactions to certain ingredients or with problems digesting lactose. Additionally, patients with hypersensitivity to the drug, those with kidney or liver dysfunction, individuals with heart disease, the elderly, and patients allergic to certain dyes should use this medication cautiously. Although rare, serious side effects may occur during treatment, so if symptoms such as difficulty breathing, skin rash, blood disorders, liver dysfunction, muscle pain, cardiac rhythm abnormalities, or consciousness disturbances appear, immediate discontinuation and consultation with a doctor are necessary. During treatment, regular blood tests and liver and kidney function tests should be conducted, and if symptoms do not improve, other treatment methods should be considered. This medication dissolves in the mouth but is not absorbed through the mucosa, so it must be swallowed with water. Caution should be taken as the effectiveness of this medication may decrease when used with specific phosphate binders in patients undergoing dialysis. Moreover, concurrent use with certain antifungals or anticancer drugs may reduce the effectiveness of this medication, so consultation with a doctor or pharmacist is necessary. Elderly patients may require dosage adjustments due to increased drug concentration from kidney function decline. Women who are pregnant or may become pregnant should only take this medication under a doctor's supervision if necessary, and breastfeeding women should discontinue nursing if using this drug. The safety of this medication in children has not been sufficiently established, so its use is not recommended. Lastly, when taking this medication, symptoms of gastric cancer may be masked, so it is safe to confirm malignancy before use.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • shortness of breath
  • generalized rash
  • angioedema
  • facial swelling
  • oropharyngeal swelling
  • urticaria
  • pancytopenia
Show 80 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Liell syndrome
  • toxic epidermal necrolysis
  • liver function impairment
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • generalized rigidity
  • myoclonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • urticaria
  • erythema
  • facial swelling
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • clay-colored stool
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • increased blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • heaviness in the head
  • reversible confusional state
  • depression
  • seizures
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light green round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.